Cited 20 time in
Anti-Melanogenesis Activity of 6-O-Isobutyrylbritannilactone fromInula britannicaon B16F10 Melanocytes and In Vivo Zebrafish Models
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jang, Dae Kil | - |
| dc.contributor.author | Chau Ha Pham | - |
| dc.contributor.author | Lee, Ik Soo | - |
| dc.contributor.author | Jung, Seung-Hyun | - |
| dc.contributor.author | Jeong, Ji Hye | - |
| dc.contributor.author | Shin, Han-Seung | - |
| dc.contributor.author | Yoo, Hee Min | - |
| dc.date.accessioned | 2023-04-27T21:40:57Z | - |
| dc.date.available | 2023-04-27T21:40:57Z | - |
| dc.date.issued | 2020-09 | - |
| dc.identifier.issn | 1420-3049 | - |
| dc.identifier.issn | 1420-3049 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/6191 | - |
| dc.description.abstract | A potential natural melanogenesis inhibitor was discovered in the form of a sesquiterpene isolated from the flowers ofInula britannica, specifically 6-O-isobutyrylbritannilactone (IBL). We evaluated the antimelanogenesis effects of IBL on B16F10 melanocytes and zebrafish embryos. As a result, we found that 3-isobutyl-1-methylxanthine (IBMX)-induced melanin production was reduced in a dose-dependent manner in B16F10 cells by IBL. We also analyzed B16F10 cells that were and were not treated with IBMX, investigating the melanin concentration, tyrosinase activity, mRNA levels. We also studied the protein expressions of microphthalmia-associated transcription factor (MITF), tyrosinase, and tyrosinase-related proteins (TRP1, and TRP2). Furthermore, we found that melanin synthesis and tyrosinase expression were also inhibited by IBL through the modulation of the following signaling pathways: ERK, phosphoinositide 3-kinase (PI3K)/AKT, and CREB. In addition, we studied antimelanogenic activity using zebrafish embryos and found that the embryos had significantly reduced pigmentation in the IBL-treated specimens compared to the untreated controls. | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | MDPI | - |
| dc.title | Anti-Melanogenesis Activity of 6-O-Isobutyrylbritannilactone fromInula britannicaon B16F10 Melanocytes and In Vivo Zebrafish Models | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3390/molecules25173887 | - |
| dc.identifier.scopusid | 2-s2.0-85090171137 | - |
| dc.identifier.wosid | 000569670600001 | - |
| dc.identifier.bibliographicCitation | MOLECULES, v.25, no.17 | - |
| dc.citation.title | MOLECULES | - |
| dc.citation.volume | 25 | - |
| dc.citation.number | 17 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
| dc.subject.keywordPlus | DHICA OXIDASE ACTIVITY | - |
| dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
| dc.subject.keywordPlus | INULA-BRITANNICA | - |
| dc.subject.keywordPlus | DOWN-REGULATION | - |
| dc.subject.keywordPlus | MELANOMA-CELLS | - |
| dc.subject.keywordPlus | TYROSINASE | - |
| dc.subject.keywordPlus | SKIN | - |
| dc.subject.keywordPlus | SESQUITERPENES | - |
| dc.subject.keywordPlus | PIGMENTATION | - |
| dc.subject.keywordPlus | MECHANISMS | - |
| dc.subject.keywordAuthor | Inula britannica | - |
| dc.subject.keywordAuthor | 6-O-isobutyrylbritannilactone (IBL) | - |
| dc.subject.keywordAuthor | melanogenesis | - |
| dc.subject.keywordAuthor | zebrafish embryos | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
